AAREY DRUGS & PHARMACEUTICALS
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Income Statement History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹419 Cr | ₹493 Cr | ₹348 Cr | ₹300 Cr | ₹355 Cr |
Sales | ₹414 Cr | ₹493 Cr | ₹348 Cr | ₹300 Cr | ₹355 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹4.70 Cr | ₹0.08 Cr | - | - | - |
Less: Excise Duty | - | - | - | - | ₹0.04 Cr |
Net Sales | ₹419 Cr | ₹493 Cr | ₹348 Cr | ₹300 Cr | ₹355 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-15 Cr | ₹4.77 Cr | ₹-1.47 Cr | ₹4.25 Cr | ₹-6.48 Cr |
Raw Material Consumed | ₹413 Cr | ₹461 Cr | ₹336 Cr | ₹286 Cr | ₹347 Cr |
Opening Raw Materials | - | - | - | - | - |
Purchases Raw Materials | - | - | - | - | - |
Closing Raw Materials | - | - | - | - | - |
Other Direct Purchases / Brought in cost | ₹413 Cr | ₹461 Cr | ₹336 Cr | ₹286 Cr | ₹347 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹0.04 Cr | ₹0.04 Cr | ₹0.00 Cr | ₹0.02 Cr | ₹0.04 Cr |
Electricity & Power | ₹0.04 Cr | ₹0.04 Cr | ₹0.00 Cr | ₹0.02 Cr | ₹0.04 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹0.63 Cr | ₹0.67 Cr | ₹0.20 Cr | ₹0.29 Cr | ₹0.37 Cr |
Salaries, Wages & Bonus | ₹0.58 Cr | ₹0.59 Cr | ₹0.12 Cr | ₹0.24 Cr | ₹0.35 Cr |
Contributions to EPF & Pension Funds | ₹0.01 Cr | - | - | - | - |
Workmen and Staff Welfare Expenses | ₹0.03 Cr | ₹0.08 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.01 Cr |
Other Employees Cost | ₹0.01 Cr | - | ₹0.04 Cr | ₹0.02 Cr | ₹0.00 Cr |
Other Manufacturing Expenses | ₹7.75 Cr | ₹8.00 Cr | ₹4.55 Cr | ₹1.54 Cr | ₹1.94 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | - | - | - | - | - |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹7.75 Cr | ₹8.00 Cr | ₹4.55 Cr | ₹1.54 Cr | ₹1.94 Cr |
General and Administration Expenses | ₹3.09 Cr | ₹3.42 Cr | ₹2.00 Cr | ₹1.40 Cr | ₹1.19 Cr |
Rent , Rates & Taxes | ₹2.01 Cr | ₹1.82 Cr | ₹1.22 Cr | ₹0.56 Cr | ₹0.69 Cr |
Insurance | ₹0.06 Cr | ₹0.15 Cr | ₹0.14 Cr | ₹0.28 Cr | ₹0.03 Cr |
Printing and stationery | ₹0.03 Cr | ₹0.05 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Professional and legal fees | ₹0.59 Cr | ₹0.70 Cr | ₹0.21 Cr | ₹0.17 Cr | ₹0.18 Cr |
Traveling and conveyance | ₹0.06 Cr | ₹0.17 Cr | ₹0.07 Cr | ₹0.09 Cr | ₹0.05 Cr |
Other Administration | ₹0.34 Cr | ₹0.53 Cr | ₹0.34 Cr | ₹0.28 Cr | ₹0.22 Cr |
Selling and Distribution Expenses | ₹1.30 Cr | ₹2.15 Cr | ₹1.86 Cr | ₹3.37 Cr | ₹2.28 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹0.14 Cr | ₹0.04 Cr | ₹1.62 Cr | ₹3.05 Cr | ₹1.98 Cr |
Miscellaneous Expenses | ₹0.90 Cr | ₹0.97 Cr | ₹0.66 Cr | ₹0.06 Cr | ₹0.03 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | ₹0.45 Cr | ₹0.11 Cr | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹0.45 Cr | ₹0.86 Cr | ₹0.66 Cr | ₹0.06 Cr | ₹0.03 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹411 Cr | ₹481 Cr | ₹344 Cr | ₹297 Cr | ₹347 Cr |
Operating Profit (Excl OI) | ₹7.72 Cr | ₹11 Cr | ₹4.65 Cr | ₹3.23 Cr | ₹7.89 Cr |
Other Income | ₹2.73 Cr | ₹2.67 Cr | ₹7.02 Cr | ₹6.69 Cr | ₹4.34 Cr |
Interest Received | ₹2.63 Cr | ₹2.01 Cr | ₹2.43 Cr | ₹2.66 Cr | ₹2.08 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | - | ₹0.15 Cr | ₹0.00 Cr | - | - |
Others | ₹0.10 Cr | ₹0.51 Cr | ₹4.58 Cr | ₹4.03 Cr | ₹2.26 Cr |
Operating Profit | ₹10 Cr | ₹14 Cr | ₹12 Cr | ₹9.92 Cr | ₹12 Cr |
Interest | ₹2.87 Cr | ₹2.04 Cr | ₹2.44 Cr | ₹1.79 Cr | ₹2.23 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹2.54 Cr | ₹1.81 Cr | ₹2.22 Cr | ₹1.66 Cr | ₹1.40 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹0.32 Cr | ₹0.13 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.82 Cr |
Other Interest | ₹0.01 Cr | ₹0.10 Cr | ₹0.12 Cr | ₹0.03 Cr | ₹0.01 Cr |
PBDT | ₹7.58 Cr | ₹12 Cr | ₹9.22 Cr | ₹8.14 Cr | ₹9.99 Cr |
Depreciation | ₹1.57 Cr | ₹1.99 Cr | ₹0.92 Cr | ₹0.89 Cr | ₹1.01 Cr |
Profit Before Taxation & Exceptional Items | ₹6.01 Cr | ₹10 Cr | ₹8.30 Cr | ₹7.24 Cr | ₹8.99 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹6.01 Cr | ₹10 Cr | ₹8.30 Cr | ₹7.24 Cr | ₹8.99 Cr |
Provision for Tax | ₹2.24 Cr | ₹3.48 Cr | ₹1.79 Cr | ₹1.45 Cr | ₹2.44 Cr |
Current Income Tax | ₹1.78 Cr | ₹2.61 Cr | ₹1.66 Cr | ₹1.50 Cr | ₹2.25 Cr |
Deferred Tax | ₹-0.04 Cr | ₹-0.11 Cr | ₹0.12 Cr | ₹-0.05 Cr | ₹0.19 Cr |
Other taxes | ₹0.50 Cr | ₹0.98 Cr | - | - | - |
Profit After Tax | ₹3.77 Cr | ₹6.56 Cr | ₹6.51 Cr | ₹5.79 Cr | ₹6.54 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹3.77 Cr | ₹6.56 Cr | ₹6.51 Cr | ₹5.79 Cr | ₹6.54 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹45 Cr | ₹38 Cr | ₹32 Cr | ₹26 Cr | ₹19 Cr |
Appropriations | ₹48 Cr | ₹45 Cr | ₹38 Cr | ₹32 Cr | ₹26 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | - | - | - | - | - |
Equity Dividend % | - | - | - | - | ₹1.00 |
Earnings Per Share | ₹1.49 | ₹2.58 | ₹2.79 | ₹2.48 | ₹2.80 |
Adjusted EPS | ₹1.49 | ₹2.58 | ₹2.79 | ₹2.48 | ₹2.80 |
Compare Income Statement of peers of AAREY DRUGS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AAREY DRUGS & PHARMACEUTICALS | ₹125.6 Cr | 12% | -5.9% | 84.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹388,812.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹120,673.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,679.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,152.0 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹91,234.9 Cr | -1.6% | -7% | 23.8% | Stock Analytics |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AAREY DRUGS & PHARMACEUTICALS | 12% |
-5.9% |
84.1% |
SENSEX | -0.4% |
-0.9% |
25.8% |
You may also like the below Video Courses